Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Critical Care ClinicsReferences
- Outcome and survival of 88 patients with urea cycle disorders: a retrospective evaluation.Eur J Pediatr. 2003; 162: 410-416
- Neonatal onset ornithine transcarbamylase deficiency: a retrospective analysis.J Pediatr. 1999; 134: 268-272
- Neurodevelopmental outcome of long-term therapy of urea cycle disorders in Japan.J Inherit Metab Dis. 1998; 21: 151-159
- An integrated approach to the diagnosis and prospective management of partial ornithine transcarbamylase deficiency.Pediatrics. 2002; 109: 150-152
- In vivo urea cycle flux distinguishes and correlates with phenotypic severity in disorders of the urea cycle.Proc Natl Acad Sci USA. 2000; 97: 8021-8026
- Problems in the management of urea cycle disorders.Mol Genet Metab. 2004; 81: S86-S91
- Proceedings of a consensus conference for the management of patients with urea cycle disorders.J Pediatr. 2001; 138: S6-S10
- Laboratory evaluation of urea cycle disorders.J Pediatr. 2001; 138: S21-S29
- Protein and amino acid requirements and the composition of complementary foods.J Nutr. 2003; 133: 2953S-2961S
- Laboratory support of the clinical nutrition service.Clin Chem Lab Med. 2000; 38: 693-714
- Mechanisms of hyperammonemia.Clin Chem Lab Med. 2002; 40: 653-662
- Glutamate transporter and receptor function in disorders of ammonia metabolism.Ment Retard Dev Disabil Res Rev. 2001; 7: 276-279
- Localized proton MR spectroscopy in infants with urea cycle defect.AJNR Am J Neuroradiol. 2001; 22: 834-837
- Arginases I and II: do their functions overlap?.Mol Genet Metab. 2004; 81: S38-S44
- Clinical consequences of urea cycle enzyme deficiencies and potential links to arginine and nitric oxide metabolism.J Nutr. 2004; 134: S2775-S2797
- Severe liver fibrosis in argininosuccinic aciduria.Arch Pathol Lab Med. 1986; 110: 136-140
- Differential utilization of systemic and enteral ammonia for urea synthesis in control subjects and ornithine transcarbamylase deficiency carriers.Am J Clin Nutr. 2003; 78: 749-755
- Exercise promotes BCAA catabolism: effects of BCAA supplementation on skeletal muscle during exercise.J Nutr. 2004; 134: 1583S-1587S
- Metabolic bases of amino acid requirements in acute diseases.Curr Opin Clin Nutr Metab Care. 2002; 5: 189-197
- Effect of alternative pathway therapy on branched chain amino acid metabolism in urea cycle disorder patients.Mol Genet Metab. 2004; 81: S79-S85
- Regulation of skeletal muscle protein metabolism in catabolic states.Curr Opin Clin Nutr Metab Care. 2005; 8: 61-65
- Restoration of ureagenesis in N-acetylglutamate synthase deficiency by N-carbamylglutamate.J Pediatr. 2004; 145: 552-554
- The nutritional management of urea cycle disorders.J Pediatr. 2001; 138: S40-S45
- New secondary metabolites of phenylbutyrate in humans and rats.Drug Metab Dispos. 2004; 32: 10-19
- Citrate therapy in argininosuccinate lyase deficiency.J Pediatr. 1990; 117: 102-105
- Sodium citrate supplementation in inborn argininosuccinate lyase deficiency: a study in a 5-year-old patient under total parenteral nutrition.Eur J Pediatr. 1995; 154: 909-914
- Protein and amino acid metabolism in human muscle.Adv Exp Med Biol. 1998; 441: 307-319
- Leucine. A possible regulator of protein turnover in muscle.J Clin Invest. 1975; 56: 1250-1261
- Potential role of leucine metabolism in the leucine-signaling pathway involving mTOR.Am J Physiol Endocrinol Metab. 2003; 285: E854-E863
- Allopurinol challenge test in children.J Inherit Metab Dis. 1992; 15: 707-712
Article info
Footnotes
Dr. Summar acknowledges the support of NIH grants MOI-RR-0095 and U54-RR-019453.
Complete financial disclosure information for each author is provided in the frontmatter of this supplement on page iii.